Filoramo Michael, Contractor Renish, Chandramohan Deepak, Singh Prabhat, Jena Nihar, Simhadri Prathap Kumar
FSU College of Medicine Daytona Beach Florida USA.
UAB School of Medicine Birmingham Alabama USA.
Clin Case Rep. 2024 Aug 10;12(8):e9308. doi: 10.1002/ccr3.9308. eCollection 2024 Aug.
Both C-anti-neutrophil cytoplasmic antibody (ANCA) and P-ANCA vasculitis were reported to be associated with COVID-19 infection. The ideal management of COVID-19-associated ANCA vasculitis is unclear, as the experiences were limited to case reports. We presented a case of COVID-19-associated C-ANCA vasculitis, successfully treated with steroids and rituximab therapy without any significant adverse reactions.
Am J Case Rep. 2024-9-30
Arch Pediatr. 2023-1
Rheumatology (Oxford). 2022-8-30
JAMA Netw Open. 2023-10-2
J Med Case Rep. 2023-8-26
Curr Opin Allergy Clin Immunol. 2023-4-1
Am J Kidney Dis. 2021-10
N Engl J Med. 2020-2-13
N Engl J Med. 2014-11-6
N Engl J Med. 2010-7-15
N Engl J Med. 2010-7-15